BLACKBAUD INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BLACKBAUD INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $242.61M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $215.00M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $231.99M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $223.62M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $237.84M | Feb 23, 2021 |
| FY2020 | Sep 30, 2019 | $221.12M | Feb 23, 2021 |
| FY2020 | Jun 30, 2019 | $225.63M | Feb 23, 2021 |
| FY2020 | Mar 31, 2019 | $215.83M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $221.22M | Feb 20, 2020 |
| FY2019 | Sep 30, 2018 | $209.53M | Feb 20, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $1.11B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.06B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $927.74M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $913.22M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $900.42M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $848.61M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $788.49M | Feb 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $663.29M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $631.43M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $599.06M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $552.72M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $484.55M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $123.03M | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $116.32M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $127.05M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $118.76M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $121.30M | Feb 23, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.97M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($299.52M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $3.02M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($45.41M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $5.70M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($13.62M) | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $4.88M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $11.82M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $4.64M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $1.32M | Feb 23, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.75M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($271.38M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $46.35M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($28.49M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $24.91M | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | ($850.0K) | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | $10.09M | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | $19.58M | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | $8.42M | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | $3.59M | Feb 23, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.13M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $153.68M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $147.47M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $156.91M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $124.57M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $100.15M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $106.16M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $98.81M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $89.91M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $77.18M | Feb 25, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.55M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $295.97M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $199.63M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $203.89M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $213.66M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $147.96M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $182.48M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $201.39M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $176.29M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $102.28M | Feb 25, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.77M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $7.44M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.69M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $12.29M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $11.66M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $29.69M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $11.49M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $14.72M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $10.21M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $13.91M | Feb 25, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.39B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.50B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.91B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.99B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.97B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.04B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.99B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.62B | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $943.18M | Feb 25, 2015 |
| FY2014 | Dec 31, 2013 | $706.61M | Feb 25, 2015 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.31B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.10B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.25B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $2.25B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.62B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.60B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.24B | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $757.27M | Feb 25, 2015 |
| FY2014 | Dec 31, 2013 | $545.07M | Feb 25, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.05M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $126.84M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $809.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $744.03M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $717.06M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $426.15M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $396.76M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $373.78M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $336.29M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $269.08M | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $1.05B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.05B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $635.85M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $634.09M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $545.21M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $349.01M | Feb 25, 2015 |
| FY2014 | Dec 31, 2013 | $264.60M | Feb 25, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.51M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($99.46M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $198.87M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $197.05M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $242.46M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $236.71M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $234.86M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $246.48M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $131.66M | Feb 25, 2015 |
| FY2014 | Dec 31, 2013 | $125.40M | Feb 25, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.91M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $67.63M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $31.25M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $31.69M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $55.15M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $35.75M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $31.81M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $30.87M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $14.74M | Feb 25, 2015 |
| FY2014 | Dec 31, 2013 | $11.89M | Feb 25, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 18, 2026 |
| FY2024 | Dec 31, 2024 | $1.08B | Feb 21, 2025 |
| FY2023 | Dec 31, 2023 | $781.15M | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $861.99M | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $961.17M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $534.18M | Feb 23, 2021 |
| FY2019 | Dec 31, 2019 | $468.25M | Feb 20, 2020 |
| FY2014 | Dec 31, 2014 | $282.42M | Feb 25, 2015 |
| FY2013 | Dec 31, 2013 | $152.91M | Feb 26, 2014 |
| FY2013 | Dec 31, 2012 | $215.50M | Feb 26, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 23, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 23, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 23, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.71M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 49.25M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 53.63M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 53.07M | Feb 21, 2024 |